How to Go Public and Launch a Device Across the Pond

Website: http://www.onemedplace.com/forum/europe-or-bust


This workshop, which is part of the 4th Annual OneMedForum San Francisco 2011 (Jan. 11-13), will feature perspective from two companies that commercialized products in Europe before the United States. Stentys went public on the Paris stock exchange in 10/10, instead of seeking readily available private financing alternatives. JenaValve chose Europe first, and not the U.S., to establish the clinical credibility of its next-gen TAVI systems. This workshop will allow participants to hear first-hand from the companies’ CEOs about how they are succeeding in Europe, and why they have chosen Europe first as their launching pad.